Sam Gillette
Plexxikon (United States) · 24 works · 2,373 citations · h-index 6
Top works
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
- Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases
- A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design
- A Glutamine Switch Mechanism for Nucleotide Selectivity by Phosphodiesterases
- Phosphodiesterase-4 as a potential drug target
- A Glutamine Switch Mechanism for Nucleotide Selectivity by Phosphodiesterases
- Catalytic Domain Of Human Phosphodiesterase 4B In Complex With (R)-Mesopram
- Catalytic Domain Of Human Phosphodiesterase 4D In Complex With Zardaverine
- Catalytic Domain Of Human Phosphodiesterase 4D In Complex With AMP
- Catalytic Domain Of Human Phosphodiesterase 5A in Complex with GMP
- Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Vardenafil
- Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Cilomilast
- Catalytic Domain Of Human Phosphodiesterase 5A
- Catalytic Domain Of Human Phosphodiesterase 1B
- COMP 374-Potent inhibitors of mutant-B-Raf and Fms kinases designed using a scaffold-based drug discovery approach
- Catalytic Domain Of Human Phosphodiesterase 4B In Complex With 1-(2-chloro-phenyl)-3,5-dimethyl-1H-pyrazole-4-carboxylic acid ethyl ester
- Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Filaminast
- Short Article A Glutamine Switch Mechanism for Nucleotide Selectivity by Phosphodiesterases
- Catalytic Domain Of Human Phosphodiesterase 4B In Complex With Sildenafil
- Catalytic Domain Of Human Phosphodiesterase 4D In Complex With 1-(4-methoxy-phenyl)-3,5-dimethyl-1H-pyrazole-4-carboxylic acid ethyl ester